London-based Relation Therapeutics has expanded its research collaboration with GSK in an agreement worth up to $110 million (€97 million), as the AI biotech launches a foundation model designed to predict how human cells respond to experimental treatments.
Paul Rogers is a Local Democracy Reporter at the San Jose Mercury News. He specializes in covering environmental and science news, with a focus on climate change, water management, and urban development. His work has been featured in numerous publications, including The Guardian, BBC News, and The New Yorker.













.jpg?width=1200&auto=webp&quality=75&trim=44,0,45,0&crop=)